
Join to View Full Profile
200 Medical Plaza#365BLos Angeles, CA 90095
Phone+1 310-954-2692
Dr. Rastogi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Anjay Rastogi, M.D., Ph.D, is Professor and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA, Los Angeles, California. Dr. Rastogi is board certified in Nephrology and has a doctoral degree (Ph.D) in Pharmacology. Dr. Rastogi did his Internal Medicine residency and Nephrology fellowship at UCLA; he completed his graduate training under the mentorship of Nobel Laureate Professor, Louis Ignarro also at UCLA. Besides the Clinical Chief, he also serves as the Director of Nephrology Clinical Research Program, Medical Director of the ESRD | Dialysis Program, Living Kidney Donor Program, Fabry Program and PKD Program at UCLA. His research interests include cardiovascular disease, PKD, Fabry disease, anemia, diabetes and hypertension, especially in the CKD population; he has several ongoing clinical trials and studies including the NIH sponsored SPRINT study. He founded the CORE Kidney Program and the Bruin Beans Health Club at UCLA. He was awarded the UCLA Exceptional MD of the Year Award in 2014 for his demonstration of the UCLA values of Compassion, Respect, Excellence, Discovery, Integrity, and Teamwork.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Nephrology, 2003 - 2005
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2000 - 2003
University of California, Los AngelesPhD, Pharmacology, 1994 - 2000
University of California, Los AngelesPh.D., Pharmacology, 1994 - 2000
Sawai Man Singh Medical CollegeClass of 1993
Certifications & Licensure
CA State Medical License 2003 - 2027
American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- Physician of the Year University of California, Los Angeles, 2014
Clinical Trials
- Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Start of enrollment: 2007 Jan 01
- Tolvaptan Extension Study in Participants With ADPKD Start of enrollment: 2010 May 26
- Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia Start of enrollment: 2010 Sep 01
Publications & Presentations
PubMed
- Cardiovascular Complications in ADPKD.Niloufar Ebrahimi, Yasar Caliskan, Pranav S Garimella, Sol Carriazo, Fouad T Chebib
Kidney International Reports. 2025-09-01 - 1 citationsAssociation of Different Definitions of Erythropoiesis-Stimulating Agent Hyporesponsiveness with Major Adverse Cardiovascular Events: Insights from ASCEND-D.Finnian R McCausland, Sushrut S Waikar, Brian Claggett, Gearoid M McMahon, Osvaldo M V Neto
Kidney360. 2025-09-01 - Efficacy and safety of daprodustat in patients on peritoneal dialysis in the ASCEND-D trial.Indranil Dasgupta, Amy M Meadowcroft, Purav R Bhatt, Anjali Acharya, Michael Aarup
Nephrology, Dialysis, Transplantation. 2025-06-30
Journal Articles
- A Practical Guide for Treatment of Rapidly Progressive ADPKD with TolvaptanRonald D Perrone, Anjay Rastogi, Terry Watnick, Arlene B Chapman, Michal Mrug, Vicente E Torres, Fouad T Chebib, Neera K Dahl, Peter C Harris, Journal of the American Society of Nephrology
- Published Ahead of PrintAnjay Rastogi, Glenn M Chertow, Journal of the American Society of Nephrology
- Acute Kidney Injury after Pembrolizumab-Induced Adrenalitis and Adrenal InsufficiencyR. M. Hanna, U. Selamet, P. Bui, S.-F. Sun, O. Shenouda, N. Nobakht, M. Barsoum, F. Arman, and A. Rastogi, Case Reports Nephrol. Dial., 1/1/2018
Books/Book Chapters
Abstracts/Posters
- A novel presentation of Fabry DiseaseFarid Arman, Peter D. Lymberopoulos, Niloofar Nobakht, Mohammad Kamgar, Ramy M. Hanna, Carl E. Schulze, Reza Khorsan, Jean Hou, Behnoud Beroukhim, Anjay Rastogi, ASN Kidney Week, Chicago, IL, 1/1/2018
- Light chain amyloidosis in a kidney donorHania Shakeri, Niloofar Nobakht, Shaker Qaqish, Anthony Sisk, Farid Arman, Ehsan Nobakht, Mohammad Kamgar, Anjay Rastogi, ASN Kidney Week, Chicago, IL, 1/1/2018
- case of autosomal recessive Alport's syndromeFarid Arman, Misak Harutyunyan, Gurpreet Singh, Kevin C. Donohue, Maha Al baghdadi, Rohit Singhal, Niloofar Nobakht, Anjay Rastogi, ASN Kidney Week, Chicago, IL, 1/1/2018
Lectures
- Hypertension in ElderlyLos Angeles, CA - 1/1/2018
- An overview of ADPKDLos Angeles, CA - 1/1/2018
- Updates on Nephrology and ADPKDLos Angeles, CA - 1/1/2018
Other
- Renal Sympathetic Denervation for Resistant Hypertension: Rationale and ResultsSharma T, Talwar R, Goshtaseb K, and Rastogi A
1/1/2013 - Could You Have Prehypertension?Rastogi A, UCLA Division of Geriatrics Healthy Years newsletter
1/1/2008 - Take Steps Now to Preserve Your Kidney FunctionRastogi A, UCLA Division of Geriatrics Healthy Years newsletter
1/6/2007
Press Mentions
Q&A: Dr. Anjay Rastogi Aims to Raise Kidney Disease Awareness with Health ProgramMarch 30th, 2025
What to Know About Chronic Kidney Disease in the Wake of Suni Lee’s DiagnosisJuly 29th, 2024
UCLA Jonsson Comprehensive Cancer Center Researchers at ASH 2021 Annual Meeting and ExpositionDecember 14th, 2021
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
















